Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H14N2O2 |
Molecular Weight | 206.2411 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C(N)=O)(C(N)=O)C1=CC=CC=C1
InChI
InChIKey=JFZHPFOXAAIUMB-UHFFFAOYSA-N
InChI=1S/C11H14N2O2/c1-2-11(9(12)14,10(13)15)8-6-4-3-5-7-8/h3-7H,2H2,1H3,(H2,12,14)(H2,13,15)
Molecular Formula | C11H14N2O2 |
Molecular Weight | 206.2411 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Primidone, phenobarbital, and PEMA: II. Seizure protection, neurotoxicity, and therapeutic index of varying combinations in mice. | 1983 Mar |
|
Primidone, phenobarbital, and PEMA: I. Seizure protection, neurotoxicity, and therapeutic index of individual compounds in mice. | 1983 Mar |
|
Effects of encapsulation of primidone on its oxidative metabolism in rats. | 2001 |
|
Optimization of solid-phase microextraction procedures for the determination of tricyclic antidepressants and anticonvulsants in plasma samples by liquid chromatography. | 2006 Sep |
|
Simultaneous determination of antiepileptic drugs and their two active metabolites by HPLC. | 2008 Jan |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 17 01:50:26 UTC 2022
by
admin
on
Sat Dec 17 01:50:26 UTC 2022
|
Record UNII |
67CFD7341W
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7206-76-0
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
67CFD7341W
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
61371
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
1562011
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
23611
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
53221
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
Phenylethylmalonamide
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
230-583-9
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY | |||
|
DTXSID3025885
Created by
admin on Sat Dec 17 01:50:26 UTC 2022 , Edited by admin on Sat Dec 17 01:50:26 UTC 2022
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
Metabolite to parent drug ratio in non-uraemic human plasma.
METABOLITE TO PARENT DRUG RATIO
PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|